Form 4: Equillium's Principal Accounting Officer, Tom Penny, Executes Stock Sales Under 10b5-1 Plan

Tom Penny, Principal Accounting Officer of Equillium, Inc., sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On October 25, 2024, Tom Penny, the Principal Accounting Officer of Equillium, Inc., sold 683 shares of common stock at a price of $1.25 per share.
• Following this transaction, Mr. Penny directly owned 9,368 shares.
• On October 28, 2024, Mr. Penny sold an additional 2,835 shares at $1.25 per share, reducing his direct holdings to 6,533 shares.
• The sales were executed under a Rule 10b5-1 trading plan adopted on June 14, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock sales under a pre-arranged plan, which doesn't inherently indicate positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock sales by a company insider. Such transactions are common and often pre-planned to avoid accusations of insider trading, especially in the pharmaceutical industry where news can significantly impact stock prices.

Stakeholder Impact

• The stock sales by an officer could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates